Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
39.47
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Kobayashi Pharmaceutical Gross Profit Margin (Quarterly) : 49.95% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.95% |
| March 31, 2026 | 50.72% |
| December 31, 2025 | 47.47% |
| September 30, 2025 | 52.01% |
| June 30, 2025 | 52.53% |
| March 31, 2025 | 50.08% |
| December 31, 2024 | 48.01% |
| September 30, 2024 | 52.25% |
| June 30, 2024 | 53.05% |
| March 31, 2024 | 56.48% |
| December 31, 2023 | 51.40% |
| September 30, 2023 | 55.70% |
| June 30, 2023 | 57.03% |
| March 31, 2023 | 57.00% |
| December 31, 2022 | 51.37% |
| September 30, 2022 | 56.18% |
| June 30, 2022 | 57.08% |
| March 31, 2022 | 56.42% |
| December 31, 2021 | 52.83% |
| September 30, 2021 | 58.05% |
| June 30, 2021 | 58.76% |
| March 31, 2021 | 58.09% |
| December 31, 2020 | 50.93% |
| September 30, 2020 | 58.58% |
| June 30, 2020 | 58.88% |
| Date | Value |
|---|---|
| March 31, 2020 | 56.91% |
| December 31, 2019 | 49.22% |
| September 30, 2019 | 58.93% |
| June 30, 2019 | 60.32% |
| March 31, 2019 | 58.68% |
| December 31, 2018 | 57.65% |
| September 30, 2018 | 62.06% |
| June 30, 2018 | 64.05% |
| March 31, 2018 | 62.79% |
| December 31, 2017 | 56.66% |
| September 30, 2017 | 61.56% |
| June 30, 2017 | 63.24% |
| March 31, 2017 | 62.28% |
| December 31, 2016 | 54.95% |
| September 30, 2016 | 60.13% |
| June 30, 2016 | 61.43% |
| March 31, 2016 | 58.62% |
| March 31, 2015 | 54.16% |
| December 31, 2014 | 55.47% |
| September 30, 2014 | 58.53% |
| June 30, 2014 | 60.74% |
| March 31, 2014 | 54.21% |
| December 31, 2013 | 55.97% |
| September 30, 2013 | 58.70% |
| June 30, 2013 | 60.17% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Medifast, Inc. | 69.90% |
| Integrated BioPharma, Inc. | 0.29% |
| Kao Corp. | 39.51% |
| Shiseido Co., Ltd. | 79.04% |
| Skinvisible, Inc. | 0.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.84% |
| Return on Assets | 0.68% |
| Return on Invested Capital | 0.84% |
| Profit Margin (Quarterly) | 0.27% |
| Operating Margin (Quarterly) | 2.19% |
| Return on Net Operating Assets | 1.15% |